Nalbuphine for Obstetric Analgesia
| Autor: | B. A. Loughnan, R. Cattermole, M. Frank, A. M. Hitchcock, L. B. Stafford, E. J. McAteer |
|---|---|
| Rok vydání: | 1987 |
| Předmět: |
Adult
Time Factors Meperidine Sedation medicine.medical_treatment Pain relief Nalbuphine law.invention Random Allocation Fetus Randomized controlled trial Double-Blind Method law Pregnancy Statistical significance medicine Anesthesia Obstetrical Humans Pain Measurement Labor Obstetric business.industry Patient-controlled analgesia Infant Newborn Patient Acceptance of Health Care medicine.disease Pethidine Anesthesiology and Pain Medicine Morphinans Anesthesia Obstetric analgesia Apgar Score Apgar score Female medicine.symptom Analgesia business medicine.drug |
| Zdroj: | Obstetric Anesthesia Digest. 7:150-151 |
| ISSN: | 0275-665X |
| DOI: | 10.1097/00132582-198712000-00021 |
| Popis: | A double-blind, randomised study of 60 patients who received intravenous increments of nalbuphine 3 mg or pethidine 15 mg by patient-controlled analgesia during the first stage of labour, was carried out. Pain intensity, sedation, uterine contractions, maternal cardioventilatory variables and fetal heart rate were recorded as well as any side effects. Apgar scores, time to sustained respiration and resuscitative measures required for the neonate were noted at delivery. Modified neonatal neurobehavioural studies and a retrospective assessment of maternal analgesia, satisfaction and tolerance were also carried out. Group mean values of pain scores of nalbuphine-medicated primiparous women were statistically significantly lower than those of pethidine-medicated patients (p less than 0.01). Other assessments did not demonstrate a statistical significance between the two groups. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|